Overall survival and exploratory subgroup analyses from the phase 2 CodeBreaK 100 trial evaluating sotorasib in pretreated KRAS p.G12C mutated non-small cell lung cancer Meeting Abstract
| Authors: | Skoulidis, F.; Li, B. T.; Govindan, R.; Dy, G. K.; Shapiro, G.; Bauml, J.; Schuler, M. H.; Addeo, A.; Kato, T.; Besse, B.; Anderson, A.; Ang, A.; Ngarmchamnanrith, G.; Tran, Q.; Velcheti, V. |
| Abstract Title: | Overall survival and exploratory subgroup analyses from the phase 2 CodeBreaK 100 trial evaluating sotorasib in pretreated KRAS p.G12C mutated non-small cell lung cancer |
| Meeting Title: | 2021 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2021 Jun 4-8 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-05-20 |
| Language: | English |
| ACCESSION: | WOS:000708120604297 |
| DOI: | 10.1200/JCO.2021.39.15_suppl.9003 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 9003 -- Source: Wos |
